Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
4399-4413
Author(s):
J. Mascarenhas, T. I. Mughal and S. Verstovsek
Platelet Turnover in Atherothrombotic Disease
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
5328-5343
Author(s):
Marie Lordkipanidze
Sinonasal Carcinoma: Updated Phenotypic and Molecular Characterization
Journal:
Current Cancer Therapy Reviews
Volume:
8
Page:
218-224
Author(s):
Diana Bell and Ehab Y. Hanna
Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4498-4507
Author(s):
Paulus S. Rommer, Robert Patejdl and Uwe K. Zettl
Continuous Renal Replacement Therapy in Children Post-Hematopoietic Stem Cell Transplantation: The Present and the Future
Journal:
Current Stem Cell Research & Therapy
Volume:
7
Page:
381-387
Author(s):
Lama Elbahlawan and R. Ray Morrison
Editorial (Hot Topic: Genetics and Risk Assessment)
Journal:
Current Genomics
Volume:
13
Page:
417-417
Author(s):
H.-U.G. Weier and B. O'Brien
Targeted Therapy of Multiple Myeloma: The Changing Paradigm at the Beginning of the New Millennium
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
743-756
Author(s):
Fortunato Morabito, Anna Grazia Recchia, Carla Mazzone and Massimo Gentile
Novel Insights in Molecular Mechanisms of CLL
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3363-3372
Author(s):
Nicola Zanesi, Veronica Balatti, Arianna Bottoni, Carlo M. Croce and Yuri Pekarsky
5q- syndrome
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3180-3183
Author(s):
Jacqueline Boultwood, Andrea Pellagatti and James S. Wainscoat
Antiplatelet Therapy in Children: Why So Different from Adults’?
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3019-3033
Author(s):
Pier Paolo Bassareo, Vassilios Fanos, Nicoletta Iacovidou and Giuseppe Mercuro